Phase I study of the novel oral steroidal antiestrogenic agent TAS-108, ascending single dose, safety, tolerance, and pharmacokinetic parameters in healthy postmenopausal women.

被引：0
|
作者：
Kuritani, J
Abdelhameed, M
Boyeson, M
Dixon, RM
Pfefferkorn, C
Yonezawa, J
Shindo, T
Minami, Y
Buzdar, AU
机构：
[1] Taiho Pharmaceut Co Ltd, Tokyo, Japan
[2] Covance Clin Res Unit Inc, Madison, WI USA
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
456
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Safety and pharmacokinetics of TAS-108; A novel antiestrogen, in healthy Japanese postmenopausal women.
    Kumagai, Y
    Fujita, T
    Ozaki, M
    Yokota, S
    Sawada, M
    Otani, Y
    Yamaya, H
    Tsuruta, H
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P53 - P53
  • [2] Safety, Tolerability and Pharmacokinetics of TAS-108, a Novel Anti-Oestrogen, in Healthy Post-Menopausal Japanese Women: A Phase I Single Oral Dose Study
    Kumagai, Yuji
    Fujita, Tomoe
    Ozaki, Machiko
    Yokota, Shin-ichi
    Maeda, Mika
    Shida, Mizue
    Otani, Yoshio
    Yamaya, Hidetoshi
    Tsuruta, Hideo
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (05) : 352 - 359
  • [3] Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose
    Yamaya, H
    Yoshida, K
    Kuritani, J
    Yonezawa, J
    Tsuda, M
    Shindo, T
    Nagayama, S
    Buzdar, AU
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (05) : 459 - 470
  • [4] TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor α and a partial agonist on estrogen receptor β with low uterotrophic effect
    Yamamoto, Y
    Shibata, J
    Yonekura, K
    Sato, K
    Hashimoto, A
    Aoyagi, Y
    Wierzba, K
    Yano, S
    Asao, T
    Buzdar, AU
    Terada, T
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (01) : 315 - 322
  • [5] Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose. (vol 30, pg 359, 2005)
    Yamada, H
    Yoshida, K
    Kuritani, J
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (02) : 204 - 204
  • [6] A phase II, randomized, open-label, dose-finding study of TAS-108, a novel steroidal antiestrogen, administered orally in postmenopausal women with advanced or metastatic breast cancer.
    Iwata, H.
    Inaji, H.
    Nakayama, T.
    Yamamoto, N.
    Noguchi, S.
    Ikeda, T.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 195S - 196S
  • [7] A phase I, open-label, non-randomized, dose-finding safety, tolerance, and pharmacokinetic study of TAS-108 administered orally in postmenopausal female patients with breast carcinoma following standard endocrine therapies
    Noguchi, S
    Saeki, T
    Aogi, K
    Inaji, H
    Tabei, T
    Ikeda, T
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S238 - S238
  • [8] A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer
    Blakely, LJ
    Buzdar, A
    Chang, HY
    Frye, D
    Theriault, R
    Valero, V
    Rivera, E
    Booser, D
    Kuritani, J
    Tsuda, M
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5425 - 5431
  • [9] The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women
    Haemmerle, Sibylle P.
    Mindeholm, Linda
    Launonen, Aino
    Kiese, Beate
    Loeffler, Rolf
    Harfst, Evita
    Azria, Moise
    Arnold, Michel
    John, Markus R.
    [J]. BONE, 2012, 50 (04) : 965 - 973
  • [10] Assessment of uterus, bone, serum lipids, and hormones in postmenopausal breast cancer patients treated with TAS-108, a novel steroidal antiestrogen: Results of a randomized phase II study
    Nakayama, T.
    Inaji, H.
    Iwata, H.
    Yamamoto, N.
    Sato, Y.
    Tokuda, Y.
    Aogi, K.
    Saji, S.
    Ikeda, T.
    Noguchi, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345